Liposomes for scintigraphic detection of infection and inflammation.
暂无分享,去创建一个
O. Boerman | P. Laverman | Storm | Dams | Laverman | Boerman | Oyen | Corstens | E. Dams | Gert Storm | W. J. Oyen | Frans H.M. Corstens
[1] G. Scherphof,et al. Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats. , 1984, Biochimica et biophysica acta.
[2] S. Davis,et al. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. , 1993, Biochimica et biophysica acta.
[3] B D Williams,et al. Effect of liposome surface charge on the stability of technetium (99mTc) radiolabelled liposomes. , 1989, Journal of microencapsulation.
[4] V. Awasthi,et al. Dual radiolabeled liposomes: biodistribution studies and localization of focal sites of infection in rats. , 1998, Nuclear Medicine and Biology.
[5] E. Wisse,et al. UPTAKE OF LIPOSOMES BY RAT AND MOUSE HEPATOCYTES AND KUPFFER CELLS , 1983 .
[6] W. Oyen,et al. Sterically stabilized liposomes labeled with indium-111 to image focal infection. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] A. Fischman,et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] I. Kellaway,et al. Specific accumulation of technetium-99m radiolabelled, negative liposomes in the inflamed paws of rats with adjuvant induced arthritis: effect of liposome size. , 1989, Annals of the rheumatic diseases.
[9] S. Okada,et al. Liposomes prepared from synthetic amphiphiles. I. Their technetium labeling and stability. , 1989, Chemical & pharmaceutical bulletin.
[10] I. Kellaway,et al. Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis. , 1990, Annals of the rheumatic diseases.
[11] V. Caride. Technical and biological considerations on the use of radiolabeled liposomes for diagnostic imaging. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[12] P. Beaumier,et al. An efficient method for loading indium-111 into liposomes using acetylacetone. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] C. Hunt,et al. Liposome disposition in vivo II: Dose dependency. , 1982, Journal of pharmaceutical sciences.
[14] A. Bangham,et al. NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.
[15] J H Senior,et al. Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.
[16] W. Oyen,et al. In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions. , 1998, The Journal of infectious diseases.
[17] Amarnath Sharma,et al. Liposomes in drug delivery: Progress and limitations , 1997 .
[18] L. Kasi,et al. 99mTc-labelled diphytanoylphosphatidylcholine liposomes: in vitro and in vivo studies. , 1997, Journal of microencapsulation.
[19] Seeger Ll. IMAGING EVALUATION OF OSTEOMYELITIS , 1994 .
[20] S. Srivastava,et al. Radionuclide-labeled red blood cells: current status and future prospects. , 1984, Seminars in nuclear medicine.
[21] V. Torchilin. How do polymers prolong circulation time of liposomes , 1996 .
[22] J. D'haese,et al. 99mTechnetium-stannous oxinate as marker of liposome formulations. , 1996, Nuclear medicine and biology.
[23] C. Presant,et al. Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. , 1983, Science.
[24] C. Tilcock,et al. Attachment of 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[25] L. Williams,et al. Technetium-labelled liposome imaging for deep-seated infection. , 1985, The British journal of radiology.
[26] M. Senda,et al. Rapid tumor imaging by active background reduction using biotin-bearing liposomes and avidin. , 1994, Cancer research.
[27] D. Hnatowich,et al. Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] V. Torchilin,et al. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.
[29] B. Williams,et al. Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis. , 1987, Annals of the rheumatic diseases.
[30] G. Storm,et al. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. , 1993, The Journal of infectious diseases.
[31] C. Hunt,et al. Liposome disposition in vivo. III. Dose and vesicle-size effects. , 1981, Biochimica et biophysica acta.
[32] W. Oyen,et al. Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] B. Williams,et al. Inflammatory joint disease: a comparison of liposome scanning, bone scanning, and radiography. , 1988, Annals of the rheumatic diseases.
[34] L. Williams,et al. Localisation of experimental staphylococcal abscesses by 99MTC-technetium-labelled liposomes. , 1981, Journal of medical microbiology.
[35] R L Juliano,et al. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.
[36] V. Awasthi,et al. Imaging experimental osteomyelitis using radiolabeled liposomes. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] B. Goins,et al. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] T M Allen,et al. Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.
[39] T. Allen,et al. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.
[40] W. Oyen,et al. Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] P. Beaumier,et al. Encapsulation, with high efficiency, of radioactive metal ions in liposomes. , 1982, Biochimica et biophysica acta.
[42] G. Gregoriadis,et al. Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. , 1982, Life sciences.
[43] J. Dijkstra,et al. The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts. , 1981, Biochimica et biophysica acta.
[44] A. Gabizon,et al. An Improved Method for in Vivo Tracing and Imaging of Liposomes Using a Gallium 67-Deferoxamine Complex , 1988 .
[45] J. V. D. van der Meer,et al. Chemotactic peptides: new locomotion for imaging of infection? , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] W. Oyen,et al. Technetium-99m labelled liposomes to image experimental arthritis , 1997, Annals of the rheumatic diseases.
[47] Gert Storm,et al. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .
[48] M. Woodle,et al. Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.
[49] G. Gregoriadis,et al. Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats. , 1974, The Biochemical journal.
[50] W. Oyen,et al. Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[51] G. Gregoriadis,et al. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.
[52] N. Van Rooijen,et al. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.
[53] G. Storm,et al. Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. , 1992, Biochimica et biophysica acta.
[54] A. Fischman,et al. Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[55] W. Oyen,et al. Scintigraphic evaluation of experimental colitis in rabbits. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] A S Rudolph,et al. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[57] S. Bhatia,et al. Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. , 1997, Biochimica et biophysica acta.
[58] N. Oku,et al. Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes. , 1993, Nuclear medicine and biology.